Polarityte Inc (PTE) Expected to Post Earnings of -$1.04 Per Share
Wall Street brokerages forecast that Polarityte Inc (NASDAQ:PTE) will post earnings per share (EPS) of ($1.04) for the current quarter, according to Zacks. Three analysts have provided estimates for Polarityte’s earnings. The lowest EPS estimate is ($1.15) and the highest is ($0.82). Polarityte posted earnings of ($2.31) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 55%. The firm is expected to issue its next quarterly earnings results on Monday, April 15th.
On average, analysts expect that Polarityte will report full-year earnings of ($4.14) per share for the current year, with EPS estimates ranging from ($4.65) to ($3.45). For the next financial year, analysts expect that the business will post earnings of ($3.68) per share, with EPS estimates ranging from ($3.85) to ($3.39). Zacks’ EPS calculations are a mean average based on a survey of analysts that that provide coverage for Polarityte.
Polarityte (NASDAQ:PTE) last posted its quarterly earnings results on Monday, January 14th. The company reported ($0.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.06. The firm had revenue of $1.13 million for the quarter, compared to analysts’ expectations of $0.80 million. Polarityte had a negative return on equity of 258.52% and a negative net margin of 4,259.44%.
A hedge fund recently bought a new stake in Polarityte stock. Comprehensive Portfolio Management LLC bought a new position in shares of Polarityte Inc (NASDAQ:PTE) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 21,702 shares of the company’s stock, valued at approximately $232,000. Comprehensive Portfolio Management LLC owned 0.10% of Polarityte as of its most recent SEC filing. Institutional investors own 54.85% of the company’s stock.
Shares of Polarityte stock traded down $0.20 on Monday, reaching $8.61. 424,600 shares of the company’s stock were exchanged, compared to its average volume of 345,313. The stock has a market capitalization of $190.74 million, a price-to-earnings ratio of -1.77 and a beta of 1.48. Polarityte has a 52 week low of $8.46 and a 52 week high of $41.22. The company has a debt-to-equity ratio of 0.01, a quick ratio of 13.76 and a current ratio of 13.80.
PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.
Featured Story: How much money do you need to begin day trading?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.